| Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles FL Ricklefs, Q Alayo, H Krenzlin, AB Mahmoud, MC Speranza, ... Science advances 4 (3), eaar2766, 2018 | 493 | 2018 |
| Arming an oncolytic herpes simplex virus type 1 with a single-chain fragment variable antibody against PD-1 for experimental glioblastoma therapy C Passaro, Q Alayo, I DeLaura, J McNulty, K Grauwet, H Ito, V Bhaskaran, ... Clinical Cancer Research 25 (1), 290-299, 2019 | 106 | 2019 |
| The functional synergism of microRNA clustering provides therapeutically relevant epigenetic interference in glioblastoma V Bhaskaran, MO Nowicki, M Idriss, MA Jimenez, G Lugli, JL Hayes, ... Nature communications 10 (1), 442, 2019 | 104 | 2019 |
| Aurora B: a new prognostic marker and therapeutic target in cancer G Portella, C Passaro, P Chieffi Current medicinal chemistry 18 (4), 482-496, 2011 | 98 | 2011 |
| Preclinical investigation of combined gene-mediated cytotoxic immunotherapy and immune checkpoint blockade in glioblastoma MC Speranza, C Passaro, F Ricklefs, K Kasai, SR Klein, H Nakashima, ... Neuro-oncology 20 (2), 225-235, 2018 | 74 | 2018 |
| Cytomegalovirus promotes murine glioblastoma growth via pericyte recruitment and angiogenesis H Krenzlin, P Behera, V Lorenz, C Passaro, M Zdioruk, MO Nowicki, ... The Journal of clinical investigation 129 (4), 1671-1683, 2019 | 69 | 2019 |
| The oncolytic virus dl922-947 reduces IL-8/CXCL8 and MCP-1/CCL2 expression and impairs angiogenesis and macrophage infiltration in anaplastic thyroid carcinoma C Passaro, F Borriello, V Vastolo, S Di Somma, E Scamardella, ... Oncotarget 7 (2), 1500, 2016 | 67 | 2016 |
| Tumor interferon signaling is regulated by a lncRNA INCR1 transcribed from the PD-L1 locus M Mineo, SM Lyons, M Zdioruk, N von Spreckelsen, R Ferrer-Luna, H Ito, ... Molecular cell 78 (6), 1207-1223. e8, 2020 | 53 | 2020 |
| AZD1152 negatively affects the growth of anaplastic thyroid carcinoma cells and enhances the effects of oncolytic virus dl922-947 S Libertini, A Abagnale, C Passaro, G Botta, S Barbato, P Chieffi, ... Endocrine-related cancer 18 (1), 129-141, 2011 | 50 | 2011 |
| The Oncolytic Virus dl922-947 Triggers Immunogenic Cell Death in Mesothelioma and Reduces Xenograft Growth S Di Somma, CA Iannuzzi, C Passaro, IM Forte, R Iannone, V Gigantino, ... Frontiers in oncology 9, 564, 2019 | 49 | 2019 |
| High levels of GPR30 protein in human testicular carcinoma in situ and seminomas correlate with low levels of estrogen receptor‐beta and indicate a switch in estrogen … F Boscia, C Passaro, V Gigantino, S Perdonà, R Franco, G Portella, ... Journal of cellular physiology 230 (6), 1290-1297, 2015 | 47 | 2015 |
| Inhibition of Autophagy Enhances the Effects of E1A-Defective Oncolytic Adenovirus dl922–947 Against Glioma Cells In Vitro and In Vivo G Botta, C Passaro, S Libertini, A Abagnale, S Barbato, AS Maione, ... Human gene therapy 23 (6), 623-634, 2012 | 46 | 2012 |
| Toxicity and efficacy of a novel GADD34-expressing oncolytic HSV-1 for the treatment of experimental glioblastoma H Nakashima, T Nguyen, K Kasai, C Passaro, H Ito, WF Goins, I Shaikh, ... Clinical Cancer Research 24 (11), 2574-2584, 2018 | 43 | 2018 |
| PARP inhibitor olaparib increases the oncolytic activity of dl922-947 in in vitro and in vivo model of anaplastic thyroid carcinoma C Passaro, M Volpe, G Botta, E Scamardella, G Perruolo, D Gillespie, ... Molecular oncology 9 (1), 78-92, 2015 | 40 | 2015 |
| Glioblastoma infiltration of both tumor-and virus-antigen specific cytotoxic T cells correlates with experimental virotherapy responses QA Alayo, H Ito, C Passaro, M Zdioruk, AB Mahmoud, K Grauwet, X Zhang, ... Scientific reports 10 (1), 5095, 2020 | 35 | 2020 |
| Glucose impairs tamoxifen responsiveness modulating connective tissue growth factor in breast cancer cells MR Ambrosio, V D’Esposito, V Costa, D Liguoro, F Collina, M Cantile, ... Oncotarget 8 (65), 109000, 2017 | 34 | 2017 |
| Selenium supplementation modulates apoptotic processes in thyroid follicular cells IC Nettore, E De Nisco, S Desiderio, C Passaro, L Maione, M Negri, ... BioFactors 43 (3), 415-423, 2017 | 32 | 2017 |
| Ionizing radiation enhances dl922–947-mediated cell death of anaplastic thyroid carcinoma cells C Passaro, A Abagnale, S Libertini, M Volpe, G Botta, L Cella, R Pacelli, ... Endocrine-Related Cancer 20 (5), 633-647, 2013 | 22 | 2013 |
| Aurora A and B kinases-targets of novel anticancer drugs S Libertini, A Abagnale, C Passaro, G Botta, G Portella Recent patents on anti-cancer drug discovery 5 (3), 219-241, 2010 | 20 | 2010 |
| Oncolytic virus therapy alters the secretome of targeted glioblastoma cells J Godlewski, M Farhath, FL Ricklefs, C Passaro, K Kiel, H Nakashima, ... Cancers 13 (6), 1287, 2021 | 10 | 2021 |
